Is gosatuzumab (Tudavi) included in medical insurance reimbursement? What are the reimbursement rates and conditions?

Gosatuzumab (Trodelvy) is currently on the market in China, but due to its short time on the market, it has not yet been included in the scope of medical insurance reimbursement. Therefore, patients need to pay for the drug at their own expense when purchasing it domestically, and the price varies according to pharmacies in different regions. Currently, the price of gosatuzumab is approximately more than 8,000 yuan per box. The specific price will vary depending on pharmacies and regions. Patients need to consult their local hospital or pharmacy for the latest price information when purchasing.

Since gosatuzumab has not yet been included in medical insurance, patients cannot enjoy medical insurance reimbursement when purchasing the drug, and all costs must be borne by the patient. For many patients, the high price of medications can result in a significant financial burden, especially if long-term treatment is required. Therefore, when patients choose to use this drug, they usually need to discuss the treatment plan with their doctor, confirm whether the drug is suitable for use, and understand in advance the possible costs during the treatment process.

At present, the conditions for medical insurance inclusion of gosatuzumab are not clear. Whether medical insurance can cover the drug may be closely related to the drug's efficacy, clinical needs, medical insurance policies and other factors. As the clinical use data of this drug accumulates and patient demand increases, it may be re-evaluated in the future to consider whether to include it in medical insurance coverage. In this regard, patients can regularly learn from relevant medical institutions or medical insurance departments about the latest developments regarding the inclusion of drugs in medical insurance.

For patients who need to use gosatuzumab, in addition to paying attention to drug purchase channels and price information, patients can also pay attention to some drug subsidy programs or charitable assistance programs to reduce the financial burden. Certain drug manufacturing companies or NGOs may offer certain funding or support programs to help patients better afford their medications. Therefore, patients should fully understand the cost of treatment and choose a suitable purchase channel under the guidance of a doctor.

Reference materials:https://www.trodelvy.com/